Humoral response after two doses of bnt162b2 mrna vaccine has a role in predicting response after three doses that is related to plasma hiv viremia and nadir cd4+ cell count in hiv-positive patients

HIGHLIGHTS

• who: Monica Basso and colleagues from the Department of Molecular Medicine, University of Padova, Via Gabelli, Padova, Italy have published the research work: Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients, in the Journal: Vaccines 2023, 11, 82. of /2023/
• what: We demonstrated HIV patients` persistence of anti-spike IgG, with high serum levels being demonstrated in most patients, six months after the third dose of the BNT162b2 mRNA_vaccine . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.